NATIONAL HEALTHCARE CORP·4

May 22, 4:07 PM ET

LAROCHE RICHARD F JR 4

4 · NATIONAL HEALTHCARE CORP · Filed May 22, 2026

Research Summary

AI-generated summary of this filing

Updated

National Healthcare (NHC) Director Richard F. LaRoche Jr. Sells 7,500 Shares

What Happened

Richard F. LaRoche Jr., a director of National Healthcare Corp (NHC), sold 7,500 shares in an open-market transaction on May 21, 2026. The shares traded at $195.14 each, generating gross proceeds of approximately $1,463,566. This was a sale (transaction code S), which is often routine insider liquidity rather than a direct signal of company prospects.

Key Details

  • Transaction date: May 21, 2026
  • Transaction type: Open-market sale (S)
  • Shares sold: 7,500 at $195.14 per share
  • Gross proceeds: $1,463,566
  • Shares owned after transaction: Not disclosed in the provided excerpt of the Form 4 (see full filing for post-transaction holdings)
  • Filing: Form 4 filed May 22, 2026 (filed the day after the trade) — appears timely based on standard Form 4 reporting rules
  • No footnotes or special conditions (e.g., 10b5-1 plan, tax-withholding) were provided in the supplied data

Context

  • Sales by directors can be for routine diversification or personal needs and do not, by themselves, prove a change in company fundamentals.
  • This report concerns a director, not a 10% owner or insider exercising derivatives; no options exercise or gift was reported.
  • For full details (post-transaction holdings, any footnotes, and confirmations), consult the complete Form 4 filing (Accession 0001437749-26-018248).

Insider Transaction Report

Form 4
Period: 2026-05-21
Transactions
  • Sale

    Common Stock - Held in my name or my wife's name

    2026-05-21$195.14/sh7,500$1,463,566205,760 total
Holdings
  • Option to Purchase Common Stock [2022 Grant]

    Exercise: $69.19From: 2023-05-05Exp: 2027-05-04Common Stock (7,500 underlying)
    7,500
  • Option to Purchase Common Stock [2023 Grant]

    Exercise: $55.75From: 2025-05-04Exp: 2028-05-03Common Stock (7,500 underlying)
    7,500
  • Option to Purchase Common Stock [2024 Grant]

    Exercise: $96.03From: 2024-05-09Exp: 2029-05-08Common Stock (7,500 underlying)
    7,500
  • Option to Purchase Common Stock [2025 Grant]

    Exercise: $94.66From: 2026-05-08Exp: 2030-05-07Common Stock (7,500 underlying)
    7,500
  • Option to Purchase Common Stock [2026 Grant]

    Exercise: $171.42From: 2027-05-07Exp: 2031-05-06Common Stock (7,500 underlying)
    7,500
Signature
/s/ Richard LaRoche|2026-05-22

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4